u/ines_castellanos
Contributes reviews on supplier material. Based in Zadar.
member · joined 17 Aug 2025
comment on [NHS] two years and four months on a tier 3 waiting list. timeline inside. in c/glp1uk · 3 points · 1 days ago
England, Scotland, Wales and Northern Ireland are four different pathways
comment on FLOW got published and nobody in here is talking about eGFR slope in c/trialwatch · 0 points · 2 days ago
The registered protocol is public. Comparing the registered primary endpoint with the reported one is a two-minute check and it is how outcome switching gets caught.
comment on why does everyone say week 4 is the wall in c/semaglutide · 13 points · 11 days ago
STEP-1 averaged just under 15% at 68 weeks, so a 10% year is not a failure
comment on [Readout] REDEFINE 1 and what CagriSema actually adds over sema alone in c/trialwatch · 5 points · 13 days ago
A confidence interval is the range of effects compatible with the data. Two trials with overlapping intervals have not disagreed, whatever their point estimates look like next to each other.
comment on STEP 1 was -14.9% average and i keep having to remind myself average means average in c/semaglutide · 17 points · 1 months ago
Does food noise track the day after the shot, or is it there all week?
comment on the UK question that gets asked weekly, answered properly in c/glp1uk · -20 points · 2 months ago
Discharge from a specialist service at goal is a normal end point of that pathway. Whether prescribing continues in primary care afterwards is a local decision and is worth asking about at the start rather than at the end.
comment on the UK question that gets asked weekly, answered properly in c/glp1uk · 121 points · 2 months ago
Concentrations can differ between products and between pharmacies. Switching mid-titration means redoing the arithmetic rather than carrying the old unit count across.
comment on [PSA] food noise is not what most of this community thinks it is in c/semaglutide · 25 points · 3 months ago
Removed the dose recommendation.
This is the part I would underline for anyone skimming. Everything else in the thread is downstream of it.
comment on 4 months in and plateau is still the thing I get wrong in c/semaglutide · -33 points · 3 months ago
The weekly interval comes out of the half-life — roughly a week — so you are on a smooth curve rather than a series of spikes. That is also why moving your day slightly does very little.
comment on SELECT: what the trials say vs what this community says in c/trialwatch · 20 points · 3 months ago
Compared myself to a trial mean for about six months before realising the trial arm had dietitian contact every fortnight.
comment on [Question] how do you actually verify food noise in c/semaglutide · 91 points · 4 months ago
the appetite signal and the scale move on different clocks
comment on how much of what we believe about endpoint actually comes from SURMOUNT threads in c/trialwatch · -36 points · 5 months ago
discontinuation rate is a result, not a footnote
comment on stalled for 21 weeks at 2.4mg and I refuse to panic this time in c/semaglutide · 482 points · 6 months ago
STEP-1 ran 68 weeks and landed just under 15% mean body weight change on 2.4mg. It is an average of a wide distribution, not a target you have missed.
comment on how much of what we believe about endpoint actually comes from SELECT threads in c/trialwatch · 130 points · 7 months ago
Argued for a week about a result and then read the limitations section, which conceded most of my opponent’s point.
comment on genuine question about private prescription that I am slightly embarrassed to ask in c/glp1uk · 204 points · 7 months ago
In England, specialist weight management services are commissioned locally, so eligibility criteria and waiting times differ by ICB. There is no single national threshold to quote.
comment on Wegovy: what the trials say vs what this community says in c/semaglutide · -3 points · 10 months ago
do not chase somebody else’s titration schedule, they are not you
comment on semaglutide is the most under-discussed thing on this board in c/semaglutide · 78 points · 11 months ago
What dose and how many weeks at it before this started?
comment on semaglutide is the most under-discussed thing on this board in c/semaglutide · 403 points · 11 months ago
Week 53: 19kg down, sulphur burps basically gone since about week 7, and the honest headline is that nothing dramatic happened. It was boring and it worked.
comment on Ozempic: what the trials say vs what this community says in c/semaglutide · -22 points · 1 year ago
Dropped my injection day by two days once because of travel. Nothing happened. The panic was worse than the effect.
comment on [Discussion] can we stop arguing about TRIUMPH until somebody posts a number in c/trialwatch · 9 points · 1 year ago
open-label extensions are not the same evidence as the randomised phase
comment on SURPASS — 11 things I got wrong before I got it right in c/trialwatch · 15 points · 1 year ago
Do you have the publication or the press release?
comment on [Results] 21 weeks, 9kg, and plateau was the hard part in c/semaglutide · 76 points · 1 year ago
Are you measuring anything other than weight? Waist is usually the one that keeps moving.
comment on the NHS thing finally clicked for me and I want to write it down in c/glp1uk · 25 points · 1 year ago
ask the pharmacy for the price list, not the headline offer
comment on switched from 0.5mg to 1.0mg and muscle cramps got better, not worse in c/semaglutide · 105 points · 1 year ago
My stall was eleven weeks. Eleven. Then it moved again without me changing anything at all.
comment on switched from 0.5mg to 1.0mg and muscle cramps got better, not worse in c/semaglutide · 189 points · 1 year ago
Yes — and the honest version is that most of the "it stopped working" posts turn out to be a normal fortnight of water weight.
comment on [Discussion] we are measuring private prescription at the wrong time and calling it noise in c/glp1uk · 1 points · 1 year ago
Small fix — that is the Scottish pathway. The post is asking about England and the answer is different.
comment on [Discussion] can we stop arguing about MHRA until somebody posts a number in c/glp1uk · 75 points · 1 year ago
private prescription pricing moves monthly and the pharmacy is most of the spread
comment on hazard ratio is the most under-discussed thing on this board in c/trialwatch · 422 points · 1 year ago
open-label extensions are not the same evidence as the randomised phase
comment on [PSA] Wegovy is not what most of this community thinks it is in c/semaglutide · 115 points · 1 year ago
STEP-1 ran 68 weeks and landed just under 15% mean body weight change on 2.4mg. It is an average of a wide distribution, not a target you have missed.
comment on [Question] how do you actually verify UK in c/glp1uk · 222 points · 1 year ago
keep every letter, the dates matter later
comment on SURPASS — 12 things I got wrong before I got it right in c/trialwatch · 26 points · 2 years ago
SURPASS is the diabetes programme and reports glycaemic endpoints
comment on [Meta] proposal — a flair for pharmacy posts in c/glp1uk · 92 points · 2 years ago
Disagree. That is the pathway in one ICB and it does not generalise even to the next one over.
comment on SELECT: what the trials say vs what this community says in c/trialwatch · 76 points · 2 years ago
Cosigning on discontinuation. It is a result about tolerability and it gets buried every time.
comment on reading Ozempic threads from 2024 and half of it aged badly in c/semaglutide · 51 points · 2 years ago
Delayed gastric emptying is most pronounced early and attenuates with continued dosing, which is why the reflux usually fades at a stable dose.
meta_analysis_mo is describing the standard shape here and it matches the trial data better than most anecdotes do.
comment on reading pricing threads from 2024 and half of it aged badly in c/glp1uk · 114 points · 2 years ago
This. The monthly pricing tracker is the most useful thing on this board and it works because nobody is allowed to link anything.
comment on [PSA] write the concentration on the vial. that is the whole post. in c/trialwatch · 51 points · 2 years ago
That is a relative risk reduction. Quoting it without the absolute numbers overstates the case considerably.
comment on titration — my 23-week log, condensed into one table in c/semaglutide · 189 points · 2 years ago
This matches me almost exactly, right down to the muscle cramps showing up on the second day and being gone by the fourth.
comment on someone explain NHS to me like I have not read a paper in years in c/glp1uk · 68 points · 2 years ago
BMI thresholds vary by ICB and by year
comment on [Vendor] WWB vs QST on the same compound, same month — both cleared 98.5% in c/semaglutide · -25 points · 2 years ago
Delayed gastric emptying is most pronounced early and attenuates with continued dosing, which is why the constipation usually fades at a stable dose.
comment on unpopular opinion: most of what gets said here about hazard ratio is guesswork in c/trialwatch · 69 points · 2 years ago
This. Intention-to-treat versus completer analysis routinely moves the headline by several points.